38.02 USD
+0.82 (+2.2%)
At close: Feb 2, 2026
38.02 USD
0 (0%)
After Hours: 2/2/2026, 8:13:18 PM
IBEX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 88 industry peers in the IT Services industry. Both the health and profitability get an excellent rating, making IBEX a very profitable company, without any liquidiy or solvency issues. IBEX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make IBEX suitable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
- In the past year IBEX was profitable.
- IBEX had a positive operating cash flow in the past year.
- Each year in the past 5 years IBEX has been profitable.
- Each year in the past 5 years IBEX had a positive operating cash flow.
1.2 Ratios
- IBEX has a better Return On Assets (14.58%) than 93.18% of its industry peers.
- IBEX has a better Return On Equity (28.81%) than 89.77% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 21.63%, IBEX belongs to the top of the industry, outperforming 94.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROIC | 21.63% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- IBEX has a better Profit Margin (7.14%) than 73.86% of its industry peers.
- IBEX's Profit Margin has improved in the last couple of years.
- IBEX has a better Operating Margin (9.18%) than 68.18% of its industry peers.
- IBEX's Operating Margin has improved in the last couple of years.
- With a Gross Margin value of 30.62%, IBEX perfoms like the industry average, outperforming 43.18% of the companies in the same industry.
- In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
- There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 5.33 indicates that IBEX is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 5.33, IBEX belongs to the top of the industry, outperforming 80.68% of the companies in the same industry.
- The Debt to FCF ratio of IBEX is 0.05, which is an excellent value as it means it would take IBEX, only 0.05 years of fcf income to pay off all of its debts.
- IBEX's Debt to FCF ratio of 0.05 is amongst the best of the industry. IBEX outperforms 93.18% of its industry peers.
- IBEX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- With an excellent Debt to Equity ratio value of 0.01, IBEX belongs to the best of the industry, outperforming 84.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 5.33 |
ROIC/WACC2.27
WACC9.52%
2.3 Liquidity
- IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
- IBEX's Current ratio of 1.82 is in line compared to the rest of the industry. IBEX outperforms 56.82% of its industry peers.
- A Quick Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
- The Quick ratio of IBEX (1.82) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 41.96% over the past year.
- IBEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.04% yearly.
- IBEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.86%.
- Measured over the past years, IBEX shows a small growth in Revenue. The Revenue has been growing by 6.62% on average per year.
EPS 1Y (TTM)41.96%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%73.08%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.55%
3.2 Future
- IBEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.72% yearly.
- Based on estimates for the next years, IBEX will show a quite strong growth in Revenue. The Revenue will grow by 9.19% on average per year.
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 11.96 indicates a reasonable valuation of IBEX.
- 84.09% of the companies in the same industry are more expensive than IBEX, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of IBEX to the average of the S&P500 Index (28.41), we can say IBEX is valued rather cheaply.
- IBEX is valuated reasonably with a Price/Forward Earnings ratio of 10.50.
- Based on the Price/Forward Earnings ratio, IBEX is valued cheaply inside the industry as 89.77% of the companies are valued more expensively.
- IBEX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.64.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.96 | ||
| Fwd PE | 10.5 |
4.2 Price Multiples
- 88.64% of the companies in the same industry are more expensive than IBEX, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBEX indicates a somewhat cheap valuation: IBEX is cheaper than 69.32% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.42 | ||
| EV/EBITDA | 6.97 |
4.3 Compensation for Growth
- IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of IBEX may justify a higher PE ratio.
- IBEX's earnings are expected to grow with 13.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.52
PEG (5Y)0.29
EPS Next 2Y13.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for IBEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
38.02
+0.82 (+2.2%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-05 2026-02-05/amc
Inst Owners94.08%
Inst Owner Change-0.28%
Ins Owners2.8%
Ins Owner Change0.29%
Market Cap512.13M
Revenue(TTM)579.74M
Net Income(TTM)41.38M
Analysts45.71
Price Target41.82 (9.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.95%
Min EPS beat(2)20.05%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)16.83%
Min EPS beat(4)10.89%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)12.58%
EPS beat(12)10
Avg EPS beat(12)14.59%
EPS beat(16)12
Avg EPS beat(16)13.3%
Revenue beat(2)2
Avg Revenue beat(2)5.51%
Min Revenue beat(2)2.5%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.65%
Min Revenue beat(4)2.45%
Max Revenue beat(4)8.52%
Revenue beat(8)5
Avg Revenue beat(8)1.79%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)6.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.26%
EPS NY rev (1m)0%
EPS NY rev (3m)5.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.96 | ||
| Fwd PE | 10.5 | ||
| P/S | 0.88 | ||
| P/FCF | 16.42 | ||
| P/OCF | 9.56 | ||
| P/B | 3.57 | ||
| P/tB | 3.89 | ||
| EV/EBITDA | 6.97 |
EPS(TTM)3.18
EY8.36%
EPS(NY)3.62
Fwd EY9.52%
FCF(TTM)2.32
FCFY6.09%
OCF(TTM)3.98
OCFY10.46%
SpS43.04
BVpS10.66
TBVpS9.78
PEG (NY)0.52
PEG (5Y)0.29
Graham Number27.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROCE | 26.64% | ||
| ROIC | 21.63% | ||
| ROICexc | 24.4% | ||
| ROICexgc | 26.15% | ||
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% | ||
| FCFM | 5.38% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 129.83% | ||
| Cap/Sales | 3.86% | ||
| Interest Coverage | 31.53 | ||
| Cash Conversion | 76.01% | ||
| Profit Quality | 75.39% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.33 |
F-Score8
WACC9.52%
ROIC/WACC2.27
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.96%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%73.08%
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.86%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.55%
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.48%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year68.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.26%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y19.11%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
What is the valuation status for IBEX stock?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
What is the valuation of IBEX LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for IBEX LTD (IBEX) is 11.96 and the Price/Book (PB) ratio is 3.57.
Is the dividend of IBEX LTD sustainable?
The dividend rating of IBEX LTD (IBEX) is 0 / 10 and the dividend payout ratio is 0%.